Table 4.
Known antiviral activities of human defensins against group V viruses [21].
Virus\Defensin | HNP1 | HNP2 | HNP3 | HNP4 | HD5 | HD6 | HBD1 | HBD2 | HBD3 | HBD4 |
---|---|---|---|---|---|---|---|---|---|---|
Influenza A virus | Aggregates and increases neutrophil uptake of virus, inhibits PKC activation and viral envelope fusion with endosome | Aggregates and increases neutrophil uptake of virus | Aggregates and increases neutrophil uptake of virus | U | Increases neutrophil uptake of virus | U | U | U | Inhibits HA-mediated fusion and membrane protein mobility | * |
HPIV | * | * | * | * | * | * | * | U | * | * |
RSV | * | * | * | * | * | * | NE | Disrupt envelope | * | * |
VHSV | Binds to viral envelope G protein and induce TLR3 and ISG expression | * | * | * | * | * | * | * | * | * |
VSV | Prevent viral entry | * | * | * | * | * | * | * | * | * |
NE: Tested HDP had no effect, U: Antiviral mechanism is undetermined,
Yet to be tested.
Table shows most common result of HDP antiviral test.